You are here

  • Home
  • Archive
  • Volume 72, Issue 3
  • Prevention of sudden cardiac death by the wearable cardioverter defibrillator in a young patient with cardiac sarcoidosis

Article Text

Article menu

Download PDFPDF

Chest clinic
Images in thorax
Prevention of sudden cardiac death by the wearable cardioverter defibrillator in a young patient with cardiac sarcoidosis
  1. René Andrié1,
  2. Florian C Gaertner2,
  3. Dirk Skowasch1
  1. 1Department of Cardiology, University of Bonn, Bonn, Germany
  2. 2Department of Nuclear Medicine, University of Bonn, Bonn, Germany
  1. Correspondence to Dr René Andrié, Department of Internal Medicine II—Cardiology/Pneumology, University of Bonn, Sigmund-Freud-Str. 25, Bonn 53105, Germany; Rene.Andrie{at}ukb.uni-bonn.de

https://doi.org/10.1136/thoraxjnl-2016-208834

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Patients with sarcoidosis with cardiac manifestation have a worse prognosis due to sudden cardiac death. The most important predictor of survival appears to be left ventricular function.1 A 25-year-old female patient was transferred to our hospital. Initial echocardiography demonstrated a reduced ejection fraction (EF) of 30%. Based on CT scan, a diagnosis of cardiac sarcoidosis was suspected. This was proven by transbronchial biopsy. As a novel method, macrophage-directed positron emission tomography (PET)/CT using the somatostatin receptor ligand 68Ga-DOTA-TOC was used to image active inflammation in the thorax. Potential advantages of 68Ga-DOTA-TOC over 18F-FDG are a lower radiation exposure and a simplified and …

    View Full Text